Stryker announce expansion of its testing facility in India

This advanced 55,600-square-foot facility integrates infrastructure, enhanced microbiology capabilities, and a team to drive innovation and ensure product quality across its medical technology portfolio

Stryker has officially expanded its prototype and testing facility in India, marking significant growth of its R&D footprint in the country.

This advanced 55,600-square-foot facility integrates infrastructure, enhanced microbiology capabilities, and a team to drive innovation and ensure product quality across its medical technology portfolio.

New lab is equipped with state-of-the-art infrastructure for plastic 3D printing, metal machining, and a diverse range of testing capabilities, the lab supports prototyping and product assurance across Stryker’s entire product portfolio. It strengthens Stryker’s ability to conduct microbiological testing, ensuring the safety and efficacy of its medical technologies.

Ram Rangarajan, Vice President, Stryker Global Technology Center, India said, “Investing in innovation from India is a focus area for Stryker. This new lab represents our commitment to developing medical technologies that improve patient outcomes and comply with the highest regulatory standards.”

Rangarajan further said, “This lab expansion further strengthens our Stryker Global Technology Center and marks a significant milestone in our commitment towards fostering innovation from India. By leveraging the talent and expertise in the country, Stryker aims to develop medical technologies that benefit patients worldwide.”